Logo image of SQL

SEQLL INC (SQL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SQL - US81734C3043 - Common Stock

6.5991 USD
-1.67 (-20.2%)
Last: 11/13/2023, 8:16:47 PM
4.9999 USD
-1.6 (-24.23%)
After Hours: 11/13/2023, 8:16:47 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SQL. SQL was compared to 57 industry peers in the Life Sciences Tools & Services industry. SQL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SQL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SQL had negative earnings in the past year.
In the past year SQL has reported a negative cash flow from operations.
SQL Yearly Net Income VS EBIT VS OCF VS FCFSQL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -1M -2M -3M -4M

1.2 Ratios

SQL has a worse Return On Assets (-79.09%) than 91.80% of its industry peers.
Looking at the Return On Equity, with a value of -181.20%, SQL is doing worse than 90.16% of the companies in the same industry.
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROIC N/A
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQL Yearly ROA, ROE, ROICSQL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SQL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SQL Yearly Profit, Operating, Gross MarginsSQL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -1K -2K -3K -4K -5K

3

2. Health

2.1 Basic Checks

SQL does not have a ROIC to compare to the WACC, probably because it is not profitable.
SQL has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for SQL is higher compared to a year ago.
SQL Yearly Shares OutstandingSQL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
SQL Yearly Total Debt VS Total AssetsSQL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -6.09, we must say that SQL is in the distress zone and has some risk of bankruptcy.
SQL has a Altman-Z score of -6.09. This is amonst the worse of the industry: SQL underperforms 91.80% of its industry peers.
SQL has a Debt/Equity ratio of 0.50. This is a neutral value indicating SQL is somewhat dependend on debt financing.
SQL has a worse Debt to Equity ratio (0.50) than 73.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z -6.09
ROIC/WACCN/A
WACC11.75%
SQL Yearly LT Debt VS Equity VS FCFSQL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 2M -2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 5.04 indicates that SQL has no problem at all paying its short term obligations.
SQL has a Current ratio of 5.04. This is in the better half of the industry: SQL outperforms 70.49% of its industry peers.
A Quick Ratio of 5.04 indicates that SQL has no problem at all paying its short term obligations.
With a decent Quick ratio value of 5.04, SQL is doing good in the industry, outperforming 75.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.04
Quick Ratio 5.04
SQL Yearly Current Assets VS Current LiabilitesSQL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

The earnings per share for SQL have decreased strongly by -3588.50% in the last year.
The Revenue for SQL has decreased by -100.00% in the past year. This is quite bad
The Revenue for SQL have been decreasing by -43.28% on average. This is quite bad
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, SQL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.17% on average per year.
SQL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 354.84% yearly.
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SQL Yearly Revenue VS EstimatesSQL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2025 2M 4M 6M
SQL Yearly EPS VS EstimatesSQL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

SQL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SQL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQL Price Earnings VS Forward Price EarningsSQL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQL Per share dataSQL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as SQL's earnings are expected to grow with 25.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.64%
EPS Next 3Y25.17%

0

5. Dividend

5.1 Amount

SQL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SEQLL INC

NASDAQ:SQL (11/13/2023, 8:16:47 PM)

After market: 4.9999 -1.6 (-24.23%)

6.5991

-1.67 (-20.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-16 2023-03-16/amc
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner Change-99.58%
Ins Owners6727.96%
Ins Owner Change0%
Market Cap2.51M
Revenue(TTM)N/A
Net Income(TTM)-5.28M
Analysts80
Price Target3.06 (-53.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-13.6
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-12.25
FCFYN/A
OCF(TTM)-12.06
OCFYN/A
SpS0
BVpS7.67
TBVpS7.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.35%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.04
Quick Ratio 5.04
Altman-Z -6.09
F-Score1
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A
EBIT growth 1Y-48.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.06%
OCF growth 3YN/A
OCF growth 5YN/A

SEQLL INC / SQL FAQ

Can you provide the ChartMill fundamental rating for SEQLL INC?

ChartMill assigns a fundamental rating of 2 / 10 to SQL.


What is the valuation status for SQL stock?

ChartMill assigns a valuation rating of 1 / 10 to SEQLL INC (SQL). This can be considered as Overvalued.


Can you provide the profitability details for SEQLL INC?

SEQLL INC (SQL) has a profitability rating of 0 / 10.


What is the financial health of SEQLL INC (SQL) stock?

The financial health rating of SEQLL INC (SQL) is 4 / 10.